The Conference
This conference stands as a landmark event for the Botton-Champalimaud Pancreatic Cancer Centre in 2024 and will unite leading minds in translational science, oncology and surgery to tackle the complexities of pancreatic cancer.
The conference will serve as a pivotal platform for the exchange of groundbreaking insights, state-of-the-art surgical methodologies, and innovative therapeutic approaches that will ultimately enhance patient care and outcomes on a global scale.
More than 400 participants are expected in Lisbon for the 3-day multi-track event that will bring together 95 world-renowned cancer specialists for what will be an extremely stimulating scientific conference.
Botton-Champalimaud International Pancreatic Cancer Conference
Register here
Botton-Champalimaud Pancreatic Cancer Centre
The Botton-Champalimaud Pancreatic Cancer Centre - resulting from a partnership between the Champalimaud Foundation and the Mauricio and Charlotte Botton couple, is the first in the world simultaneously dedicated to the research and treatment of pancreatic cancer.
Carmen and Reinhold Würth joined the Botton-Champalimaud Pancreatic Cancer Centre initiative in 2023 and recently inaugurated the Würth Research Centre of Hope for Pancreatic Cancer.
Combining state of the art services and equipment, aimed at guaranteeing the well-being and comfort of patients, supported by the most advanced techniques, and resulting from an exclusive aesthetic approach, this centre comprises areas of research laboratories, a day hospital, a surgical centre, as well as inpatient and intensive care facilities.
